Didier Raoult
 Didier Raoult    (physician, biologist) | |
|---|---|
 | |
Didier Raoult (born March 13, 1952 in Dakar, Senegal)[1]</ref> is a French physician and microbiologist. He holds M.D. and Ph.D. degrees and specializes in infectious diseases. In 1984, Raoult created the Rickettsia Unit at Aix-Marseille University (AMU). He also teaches infectious diseases in the Faculty of Medicine of Aix-Marseille University, and since 1982 has supervised many M.D. and Ph.D. degrees.[2]
Since 2008, Raoult has been the director of the Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE; in English, Research Unit in Infectious and Tropical Emergent Diseases), collaborating with CNRS (National Center for the Scientific Research), IRD (Research for the Development Institute), INSERM (National Institute of Health and Medical Research) and the Aix Marseille University, in Marseille. His laboratory employs more than 200 people, including 86 researchers who publish between 250 and 350 papers per year and have produced more than 50 patents.[3] Raoult has also been involved in the creation of eight startups.[4]
COVID-19
On 17 March 2020, Raoult announced that a trial involving 36 patients from the south east of France supported the claim that Hydroxychloroquine and Azithromycin were effective in treating for COVID-19.[5][6][7] The French Health Minister, Olivier Véran, was reported as announcing that "new tests will now go ahead in order to evaluate the results by Professor Raoult, in an attempt to independently replicate the trials and ensure the findings are scientifically robust enough, before any possible decision might be made to roll any treatment out to the wider public".[8] In direct reference to the study conducted by Raoult and the possible health ramifications, Véran went on to state: "Dr. Raoult’s study involves 24 people. What kind of health minister would I be if, on the basis of a single study conducted on 24 people, I told French people to take a medicine that could lead to cardiac complications in some people?"[9] The French media also reported that the French pharmaceutical company Sanofi had offered French authorities millions of doses of the drug for use against COVID-19.[10][11][8]
References
- ↑ "Coronavirus et hydroxychloroquine : le professeur Raoult publie une nouvelle étude, aussitôt critiquée"
- ↑ "Soutenances de thèse | Faculté de Médecine". medecine.univ-amu.fr. Retrieved 2017-04-25.Page Module:Citation/CS1/styles.css must have content model "Sanitized CSS" for TemplateStyles (current model is "Scribunto").
- ↑ "Liste de résultats". bases-brevets.inpi.fr (in français). Retrieved 2017-04-25.Page Module:Citation/CS1/styles.css must have content model "Sanitized CSS" for TemplateStyles (current model is "Scribunto").
- ↑ "Incubation de start-ups – IHU Méditerranée Infection". mediterranee-infection.com (in français). Archived from the original on 2017-04-26. Retrieved 2017-04-25.Page Module:Citation/CS1/styles.css must have content model "Sanitized CSS" for TemplateStyles (current model is "Scribunto").
- ↑ "Coronavirus : diagnostiquons et traitons ! Premiers résultats pour la chloroquine – IHU" (in français). Retrieved 2020-03-18.Page Module:Citation/CS1/styles.css must have content model "Sanitized CSS" for TemplateStyles (current model is "Scribunto").
- ↑ France, Connexion. "French researcher posts successful Covid-19 drug trial". connexionfrance.com. Retrieved 2020-03-18.Page Module:Citation/CS1/styles.css must have content model "Sanitized CSS" for TemplateStyles (current model is "Scribunto").
- ↑ Link text, The Actual Scientific Paper Published by Didier Raoult, supporting a treatment for COVID-19 .
- ↑ a b France, Connexion. "French lab offers 'millions of doses' of Covid-19 drug". connexionfrance.com. Retrieved 2020-03-19.Page Module:Citation/CS1/styles.css must have content model "Sanitized CSS" for TemplateStyles (current model is "Scribunto").
- ↑ "In France, controversial doctor stirs coronavirus debate". Politco.com. Retrieved 2020-04-01.Page Module:Citation/CS1/styles.css must have content model "Sanitized CSS" for TemplateStyles (current model is "Scribunto").
- ↑ "Pubpeer: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial".Page Module:Citation/CS1/styles.css must have content model "Sanitized CSS" for TemplateStyles (current model is "Scribunto").
- ↑ "Pubpeer: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial - preprint".Page Module:Citation/CS1/styles.css must have content model "Sanitized CSS" for TemplateStyles (current model is "Scribunto").
This page imported content from Wikipedia on 2 April 2020.Wikipedia is not affiliated with Wikispooks. Original page source here
